Cargando…
Next generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma
Autores principales: | Li, Zejuan, Stölzel, Friedrich, Onel, Kenan, Sukhanova, Madina, Mirza, M. Kamran, Yap, Kai Lee, Borinets, Olesya, Larson, Richard A., Stock, Wendy, Sasaki, Mark M., Joseph, Loren, Raca, Gordana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575593/ https://www.ncbi.nlm.nih.gov/pubmed/25787914 http://dx.doi.org/10.1038/leu.2015.81 |
Ejemplares similares
-
Molecular Pathogenesis in Myeloid Neoplasms with Germline Predisposition
por: Gao, Juehua, et al.
Publicado: (2021) -
RCSD1-ABL1 Translocation Associated with IKZF1 Gene Deletion in B-Cell Acute Lymphoblastic Leukemia
por: Kamran, Shawana, et al.
Publicado: (2015) -
Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass
por: Bao, Haiyan, et al.
Publicado: (2019) -
Effective Immunosurveillance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
por: Kunadt, Desiree, et al.
Publicado: (2021) -
T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia
por: Alachkar, Houda, et al.
Publicado: (2015)